Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2014

01.01.2014

Findings on magnetic resonance imaging of fascicular ventricular tachycardia

verfasst von: Bernhard Herkommer, Michael Fiek, Christopher Reithmann

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Idiopathic left ventricular tachycardia (ILVT) with right bundle branch block and left axis deviation originates from the left posterior fascicle—Purkinje fiber network. Scar-related ventricular tachycardias (VTs) with Purkinje fibers as a part of the reentry circuit have also been described in patients with structural heart disease.

Methods and results

Nine patients with fascicular VT (left posterior, n = 8; left anterior, n = 1) with preserved left ventricular ejection fraction (60 ± 10 %) underwent cardiac magnetic resonance imaging (MRI) including functional analysis and delayed enhancement magnetic resonance imaging (DE-MRI). No definite structural abnormalities were detected by DE-MRI in four patients. DE-MRI revealed unifocal or multifocal areas of fibrosis or scar in three patients corresponding to the regions where typical Purkinje potentials guided successful ablation of the sustained fascicular VT. A false tendon extending from the free wall to the septum was found in one patient. Moderate reduction of left ventricular ejection fraction associated with septal or multifocal left ventricular fibrosis was detected in two patients with ventricular bigeminy originating from the left posterior fascicle. During the follow-up of 29 ± 22 months after successful catheter ablation in the nine patients, one patient with septal fibrosis detected by DE-MRI had VT recurrence and received an implantable cardioverter defibrillator.

Conclusion

Detection of local areas of fibrosis or scar by DE-MRI may help to distinguish idiopathic fascicular tachycardia from scar-related fascicular VT in patients with preserved left ventricular function.
Literatur
1.
Zurück zum Zitat Nakagawa, H., Beckman, K. J., McClelland, J. H., Wang, X., Arruda, M., Santoro, I., et al. (1993). Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation, 88, 2607–2617.PubMedCrossRef Nakagawa, H., Beckman, K. J., McClelland, J. H., Wang, X., Arruda, M., Santoro, I., et al. (1993). Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation, 88, 2607–2617.PubMedCrossRef
2.
Zurück zum Zitat Maruyama, M., Tadera, T., Miyamoto, S., & Ino, T. (2001). Demonstration of the re-entrant circuit of verapamil-sensitive idiopathic left ventricular tachycardia: direct evidence for macroreentry as the underlying mechanism. Journal of Cardiovascular Electrophysiology, 12, 968–972.PubMedCrossRef Maruyama, M., Tadera, T., Miyamoto, S., & Ino, T. (2001). Demonstration of the re-entrant circuit of verapamil-sensitive idiopathic left ventricular tachycardia: direct evidence for macroreentry as the underlying mechanism. Journal of Cardiovascular Electrophysiology, 12, 968–972.PubMedCrossRef
3.
Zurück zum Zitat Lin, D., Hsia, H. H., Gerstenfeld, D. P., Dixit, S., Callans, D. J., Nayak, H., et al. (2005). Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. Heart Rhythm, 2, 934–939.PubMedCrossRef Lin, D., Hsia, H. H., Gerstenfeld, D. P., Dixit, S., Callans, D. J., Nayak, H., et al. (2005). Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. Heart Rhythm, 2, 934–939.PubMedCrossRef
4.
Zurück zum Zitat Thakur, R. K., Klein, G. J., Sivaram, C. A., Zardini, M., Schleinkofer, D. E., Nakagawa, H., et al. (1996). Anatomic substrate for idiopathic left ventricular tachycardia. Circulation, 93, 497–501.PubMedCrossRef Thakur, R. K., Klein, G. J., Sivaram, C. A., Zardini, M., Schleinkofer, D. E., Nakagawa, H., et al. (1996). Anatomic substrate for idiopathic left ventricular tachycardia. Circulation, 93, 497–501.PubMedCrossRef
5.
Zurück zum Zitat Bogun, F., Good, E., Reich, S., Elmouchi, D., Igic, P., Tschopp, D., et al. (2006). Role of Purkinje fibers in post-infarction ventricular tachycardia. Journal of the American College of Cardiology, 48, 2500–2507.PubMedCrossRef Bogun, F., Good, E., Reich, S., Elmouchi, D., Igic, P., Tschopp, D., et al. (2006). Role of Purkinje fibers in post-infarction ventricular tachycardia. Journal of the American College of Cardiology, 48, 2500–2507.PubMedCrossRef
6.
Zurück zum Zitat Reithmann, C., Hahnefeld, A., Remp, T., & Steinbeck, G. (2007). Ventricular tachycardia with participation of the left bundle-Purkinje system in patients with structural heart disease: identification of slow conduction during sinus rhythm. Journal of Cardiovascular Electrophysiology, 18, 808–817.PubMedCrossRef Reithmann, C., Hahnefeld, A., Remp, T., & Steinbeck, G. (2007). Ventricular tachycardia with participation of the left bundle-Purkinje system in patients with structural heart disease: identification of slow conduction during sinus rhythm. Journal of Cardiovascular Electrophysiology, 18, 808–817.PubMedCrossRef
7.
Zurück zum Zitat Heidary, S., Patel, H., Chung, J., Yokota, H., Gupta, S. N., Bennett, M. V., et al. (2010). Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. Journal of the American College of Cardiology, 55, 2762–2768.PubMedCrossRef Heidary, S., Patel, H., Chung, J., Yokota, H., Gupta, S. N., Bennett, M. V., et al. (2010). Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. Journal of the American College of Cardiology, 55, 2762–2768.PubMedCrossRef
8.
Zurück zum Zitat Nazarian, S., Bluemke, D. A., Lardo, A. C., Zviman, M. M., Watkins, S. P., Dickfeld, T. L., et al. (2005). Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation, 112, 2821–2825.PubMedCentralPubMedCrossRef Nazarian, S., Bluemke, D. A., Lardo, A. C., Zviman, M. M., Watkins, S. P., Dickfeld, T. L., et al. (2005). Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation, 112, 2821–2825.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Bogun, F., Desjardins, B., Good, E., Gupta, S., Crawford, T., Oral, H., et al. (2009). Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy. Utility of identifying the ventricular arrhythmia substrate. Journal of the American College of Cardiology, 53, 1138–1145.PubMedCentralPubMedCrossRef Bogun, F., Desjardins, B., Good, E., Gupta, S., Crawford, T., Oral, H., et al. (2009). Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy. Utility of identifying the ventricular arrhythmia substrate. Journal of the American College of Cardiology, 53, 1138–1145.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Reithmann, C., Hahnefeld, A., Ulbrich, M., Matis, T., & Steinbeck, G. (2009). Different forms of ventricular tachycardia involving the left anterior fascicle in nonischemic cardiomyopathy: critical sites of the re-entrant circuit in low-voltage areas. Journal of Cardiovascular Electrophysiology, 20, 841–849.PubMedCrossRef Reithmann, C., Hahnefeld, A., Ulbrich, M., Matis, T., & Steinbeck, G. (2009). Different forms of ventricular tachycardia involving the left anterior fascicle in nonischemic cardiomyopathy: critical sites of the re-entrant circuit in low-voltage areas. Journal of Cardiovascular Electrophysiology, 20, 841–849.PubMedCrossRef
11.
Zurück zum Zitat O'Donnell, D., Cox, D., Bourke, J., Mitchell, L., & Furniss, S. (2003). Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. European Heart Journal, 24, 801–810.PubMedCrossRef O'Donnell, D., Cox, D., Bourke, J., Mitchell, L., & Furniss, S. (2003). Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. European Heart Journal, 24, 801–810.PubMedCrossRef
12.
Zurück zum Zitat Ouyang, F., Cappato, R., Ernst, S., Goya, M., Volkmer, M., Hebe, J., et al. (2002). Electroanatomic substrate of idiopathic left ventricular tachycardia. Unidirectional block and macroreentry within the Purkinje network. Circulation, 105, 462–469.PubMedCrossRef Ouyang, F., Cappato, R., Ernst, S., Goya, M., Volkmer, M., Hebe, J., et al. (2002). Electroanatomic substrate of idiopathic left ventricular tachycardia. Unidirectional block and macroreentry within the Purkinje network. Circulation, 105, 462–469.PubMedCrossRef
13.
Zurück zum Zitat Soejima, K., Stevenson, W. G., Sapp, J. L., Selwyn, A. P., Couper, G., & Epstein, L. M. (2004). Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. Journal of the American College of Cardiology, 43, 1834–1842.PubMedCrossRef Soejima, K., Stevenson, W. G., Sapp, J. L., Selwyn, A. P., Couper, G., & Epstein, L. M. (2004). Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. Journal of the American College of Cardiology, 43, 1834–1842.PubMedCrossRef
14.
Zurück zum Zitat Hsia, H. H., Callans, D. J., & Marchlinski, F. E. (2003). Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation, 108, 704–710.PubMedCrossRef Hsia, H. H., Callans, D. J., & Marchlinski, F. E. (2003). Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation, 108, 704–710.PubMedCrossRef
15.
Zurück zum Zitat McCrohon, J. A., Moon, J. C., Prasad, S. K., McKenna, W., Lorenz, C. H., Coats, A. J. S., et al. (2003). Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 108, 54–59.PubMedCrossRef McCrohon, J. A., Moon, J. C., Prasad, S. K., McKenna, W., Lorenz, C. H., Coats, A. J. S., et al. (2003). Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 108, 54–59.PubMedCrossRef
16.
Zurück zum Zitat De Cobelli, F., Pieroni, M., Esposito, A., Chimenti, C., Belloni, E., Mellone, R., et al. (2006). Delayed gadolinium-enhanced cardiovascular magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. Journal of the American College of Cardiology, 47, 1649–1654.PubMedCrossRef De Cobelli, F., Pieroni, M., Esposito, A., Chimenti, C., Belloni, E., Mellone, R., et al. (2006). Delayed gadolinium-enhanced cardiovascular magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. Journal of the American College of Cardiology, 47, 1649–1654.PubMedCrossRef
17.
Zurück zum Zitat Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., et al. (2006). Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Journal of the American College of Cardiology, 48, 1977–1985.PubMedCrossRef Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., et al. (2006). Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. Journal of the American College of Cardiology, 48, 1977–1985.PubMedCrossRef
18.
Zurück zum Zitat Yarlagadda, R. K., Iwai, S., Stein, K. M., Markowitz, S. M., Shah, B. K., Cheung, J. W., et al. (2005). Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation, 112, 1092–1097.PubMedCrossRef Yarlagadda, R. K., Iwai, S., Stein, K. M., Markowitz, S. M., Shah, B. K., Cheung, J. W., et al. (2005). Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation, 112, 1092–1097.PubMedCrossRef
Metadaten
Titel
Findings on magnetic resonance imaging of fascicular ventricular tachycardia
verfasst von
Bernhard Herkommer
Michael Fiek
Christopher Reithmann
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2014
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-013-9850-2

Weitere Artikel der Ausgabe 1/2014

Journal of Interventional Cardiac Electrophysiology 1/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.